HomeCompareINGEF vs KMB

INGEF vs KMB: Dividend Comparison 2026

INGEF yields 2.50% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 INGEF wins by $275.1K in total portfolio value· pulled ahead in Year 4
10 years
INGEF
INGEF
● Live price
2.50%
Share price
$2.52
Annual div
$0.06
5Y div CAGR
57.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$321.0K
Annual income
$174,317.89
Full INGEF calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.47
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,211.33
Full KMB calculator →

Portfolio growth — INGEF vs KMB

📍 INGEF pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodINGEFKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, INGEF + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
INGEF pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

INGEF
Annual income on $10K today (after 15% tax)
$212.90/yr
After 10yr DRIP, annual income (after tax)
$148,170.21/yr
KMB
Annual income on $10K today (after 15% tax)
$445.84/yr
After 10yr DRIP, annual income (after tax)
$4,429.63/yr
At 15% tax rate, INGEF beats the other by $143,740.58/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of INGEF + KMB for your $10,000?

INGEF: 50%KMB: 50%
100% KMB50/50100% INGEF
Portfolio after 10yr
$183.4K
Annual income
$89,764.60/yr
Blended yield
48.94%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

INGEF
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
1.4
Piotroski
7/9
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.5% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

INGEF buys
0
KMB buys
0
No recent congressional trades found for INGEF or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricINGEFKMB
Forward yield2.50%5.25%
Annual dividend / share$0.06$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR57.4%17%
Portfolio after 10y$321.0K$45.9K
Annual income after 10y$174,317.89$5,211.33
Total dividends collected$285.3K$21.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold

Year-by-year: INGEF vs KMB ($10,000, DRIP)

YearINGEF PortfolioINGEF Income/yrKMB PortfolioKMB Income/yrGap
1$11,094$394.25$11,314$613.68$220.00KMB
2$12,514$643.41$12,865$759.19$351.00KMB
3$14,458$1,067.62$14,709$943.96$251.00KMB
4← crossover$17,284$1,814.41$16,919$1,180.17+$365.00INGEF
5$21,685$3,190.84$19,588$1,484.33+$2.1KINGEF
6$29,092$5,888.91$22,838$1,879.06+$6.3KINGEF
7$42,750$11,621.65$26,832$2,395.60+$15.9KINGEF
8$70,864$25,121.88$31,788$3,077.63+$39.1KINGEF
9$137,083$61,258.30$38,000$3,986.82+$99.1KINGEF
10$320,997$174,317.89$45,872$5,211.33+$275.1KINGEF

INGEF vs KMB: Complete Analysis 2026

INGEFStock

Ingenia is an S&P/ASX 200 entity and listed on the Australian Securities Exchange under the stock market trading code 'INA'. With a positive impact on more than 10,850 residents each and every day, our commitment to all stakeholders is to perform with integrity, foster respect for all and build community through continuous improvement in everything we do. In addition to the Group's on balance sheet portfolio of 99 communities, Ingenia's portfolio includes: five greenfield lifestyle community developments owned through a development Joint Venture with Sun Communities, Inc (NYSE: SUI); and six established communities through the Group's managed funds. In addition to ownership interests in the JV and funds, Ingenia receives fees for services provided to these entities. The Group is supported by over 4,000 investors and more than 1,200 employees dedicated to creating community for our residents and guests.

Full INGEF Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this INGEF vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

INGEF vs SCHDINGEF vs JEPIINGEF vs OINGEF vs KOINGEF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.